Hot Investor Mandate 4: Boston-Based Family Office Invests Up to $20M in Life Science Companies

23 Nov

A private, Boston-based family office is currently interested in investing into privately held companies in the life science space. The firm is very flexible and nimble due to its capital base and is able to make investments ranging anywhere from $500,000 to $20 million and more into a given company. The firm is currently looking for companies located throughout the United States. The firm generally would only act as a co-investor from companies located outside the United States.

The firm is open to sectors and subsectors in the life science space including healthcare IT, medical devices, and diagnostics. For devices and diagnostics, the firm is looking for companies that have significant clinical data. Current portfolio companies include those working with antiviral therapies, cloud-based laboratory services, anticoagulant therapies, orthotics and prosthetics, medical devices and diagnostics for male lower urinary tract symptoms, and therapeutics for dermatology and aesthetics.

The firm is looking for companies with experienced manage teams and generally looks to take a board seat following investment. Due to the firm’s capital base they can be more flexible in terms of investment timeframe and have a longer exit horizon than other investors.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: